Related Experiment Video
Updated: May 12, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia
Jasna Dietz1, Thomas Kaercher, Anne-Theres Schneider
1German Competence Centre for Children with Ectodermal Dysplasias, Department of Pediatrics, University of Erlangen-Nürnberg, Erlangen, Germany.
X-linked hypohidrotic ectodermal dysplasia (XLHED) affects airways and eyes, causing asthma-like symptoms and dry eye even in young children. Early screening and monitoring are crucial for managing these chronic XLHED complications.
Area of Science:
- Genetics and Molecular Biology
- Pulmonology
- Ophthalmology
Background:
- X-linked hypohidrotic ectodermal dysplasia (XLHED) is primarily known for its effects on hair, teeth, and sweat glands.
- The impact of ectodysplasin deficiency on airway and ocular glands, leading to chronic health issues, is often underappreciated.
Purpose of the Study:
- To investigate the pulmonary and ophthalmologic manifestations of XLHED in male children and adults.
- To assess the early onset and prevalence of airway constriction, inflammation, and ocular abnormalities in XLHED patients.
Main Methods:
- Pulmonary function tests and fractional exhaled nitric oxide measurements were conducted.
- Ophthalmologic assessments were performed to evaluate ocular health.
- Data from 12 male children and 14 male adults with XLHED were compared to 12 healthy controls.
Main Results:
- Airway constriction and inflammation signs were observed in 8 children and 10 adults with XLHED.
- Early-onset ocular abnormalities, including increased tear osmolarity and reduced tear film break-up time, were prevalent.
- Abnormalities in pulmonary and ocular systems were found even in XLHED subjects without prior asthma or dry eye history.
Conclusions:
- XLHED patients exhibit a high prevalence of asthma-like symptoms and dry eye problems from a young age (as early as 6 years).
- Regular screening, monitoring, and early therapeutic interventions are recommended for XLHED patients starting in childhood.
Related Concept Videos
Pleiotropy
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

